Literature DB >> 16075462

Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11.

Chian-Feng Chen1, Shiou-Hwei Yeh, Ding-Shinn Chen, Pei-Jer Chen, Yuh-Shan Jou.   

Abstract

A novel 1-cM (1.8 Mb) homozygous deletion (HD) on 13q12.11 was identified in a human hepatocellular carcinoma (HCC) cell line, SK-Hep-1, after high-density genetic marker scan and Southern blotting analysis. A loss of heterozygosity (LOH) analysis indicated that LOH frequency of the HD region in 48 pairs of HCC tissues was 52%. Interestingly, the occurrence of LOH in the 13q12.11 HD region is significantly associated with early-onset HCC, inferred from Fisher's exact test (P = 0.0047) and Mann-Whitney test (P = 0.023). Since the novel 1-cM (1.8 Mb) HD region is gene-rich with more than 37 predicted transcripts, we used a candidate gene approach by examining down-regulation of known tumor suppressor genes (TSGs), including LATS2, TG737, CRYL1, and GJB2, in HCC tissues. We detected only 14% down-regulation of the LAST2 gene that flanks the outside of the HD, in HCC tissues, by quantitative RT-PCR assays. However, we observed significant down-regulation of the TG737, CRYL1, and GJB2 genes located within the HD in 59, 64, and 71% of HCC tissues, respectively. Together, our results indicated that the identified 13q12.11 HD region contained at least three significant down-regulated TSGs, and preferential LOH in early-onset HCC patients is a putative tumor suppressor locus in HCC. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16075462     DOI: 10.1002/gcc.20247

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  16 in total

1.  Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.

Authors:  Leo L Studach; Stephan Menne; Stefano Cairo; Marie Annick Buendia; Ronald L Hullinger; Lydie Lefrançois; Philippe Merle; Ourania M Andrisani
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

2.  The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1.

Authors:  Yael Aylon; Yaara Ofir-Rosenfeld; Norikazu Yabuta; Eleonora Lapi; Hiroshi Nojima; Xin Lu; Moshe Oren
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

3.  Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication.

Authors:  Wen-Horng Wang; Leo L Studach; Ourania M Andrisani
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

4.  Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma.

Authors:  Tomoe Lu; Hiroshi Hano; Chenxi Meng; Keisuke Nagatsuma; Satoru Chiba; Masahiro Ikegami
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

5.  Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility.

Authors:  Timothy M Pawlik; Ana L Gleisner; Robert A Anders; Lia Assumpcao; Warren Maley; Michael A Choti
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

6.  Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis.

Authors:  Zhi Song; Ren Li; Nan You; Kaishan Tao; Kefeng Dou
Journal:  Mol Biol Rep       Date:  2010-03-19       Impact factor: 2.316

7.  MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.

Authors:  Ge Zhao; Ting Wang; Qi-Ke Huang; Meng Pu; Wei Sun; Zhuo-Chao Zhang; Rui Ling; Kai-Shan Tao
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

8.  Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

Authors:  Martin L Sos; Kathrin Michel; Thomas Zander; Jonathan Weiss; Peter Frommolt; Martin Peifer; Danan Li; Roland Ullrich; Mirjam Koker; Florian Fischer; Takeshi Shimamura; Daniel Rauh; Craig Mermel; Stefanie Fischer; Isabel Stückrath; Stefanie Heynck; Rameen Beroukhim; William Lin; Wendy Winckler; Kinjal Shah; Thomas LaFramboise; Whei F Moriarty; Megan Hanna; Laura Tolosi; Jörg Rahnenführer; Roel Verhaak; Derek Chiang; Gad Getz; Martin Hellmich; Jürgen Wolf; Luc Girard; Michael Peyton; Barbara A Weir; Tzu-Hsiu Chen; Heidi Greulich; Jordi Barretina; Geoffrey I Shapiro; Levi A Garraway; Adi F Gazdar; John D Minna; Matthew Meyerson; Kwok-Kin Wong; Roman K Thomas
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

Review 9.  Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.

Authors:  De-Leung Gu; Yen-Hsieh Chen; Jou-Ho Shih; Chi-Hung Lin; Yuh-Shan Jou; Chian-Feng Chen
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

10.  Investigation of the miR16-1 (C > T) + 7 Substitution in Seven Different Types of Cancer from Three Ethnic Groups.

Authors:  Hulya Yazici; Jennifer Zipprich; Tao Peng; Elif Z Akisik; Hulya Tigli; Mustafa Isin; Ebru E Akisik; Mary Beth Terry; Ruby T Senie; Lequn Li; Minhao Peng; Zhiming Liu; Nejat Dalay; Regina M Santella
Journal:  J Oncol       Date:  2009-10-26       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.